Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
Inflammatory Breast Cancer (IBC) is a highly aggressive form of cancer characterized by high rates of proliferation, lymphangiogenesis and metastasis, and an overall poor survival. As regular green tea consumption has been associated with improved prognosis of breast cancer patients, including decre...
Main Authors: | Nora D Mineva, K Eric Paulson, Stephen P Naber, Amy S Yee, Gail E Sonenshein |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3770659?pdf=render |
Similar Items
-
Epigallocatechin gallate: a review
by: L. Bartosikova, et al.
Published: (2018-10-01) -
Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
by: Ling Lin, et al.
Published: (2021-11-01) -
Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
by: Yun-Ju Huang, et al.
Published: (2020-10-01) -
The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
by: Víctor Marín, et al.
Published: (2023-06-01) -
Expression of genes modulated by epigallocatechin-3-gallate in breast cancer cells
by: Bogacz Anna, et al.
Published: (2018-09-01)